SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-045169
Filing Date
2021-04-01
Accepted
2021-04-01 06:55:38
Documents
2
Period of Report
2021-03-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2111526d1_8k.htm 8-K 23212
2 EXHIBIT 99.1 tm2111526d1_ex99-1.htm EX-99.1 8297
  Complete submission text file 0001104659-21-045169.txt   32795
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 21795987
SIC: 2834 Pharmaceutical Preparations